Tyroid and Struma
-
Upload
sri-ulandari-a-taufan -
Category
Documents
-
view
228 -
download
0
Transcript of Tyroid and Struma
-
7/30/2019 Tyroid and Struma
1/52
Ihsanil husna
-
7/30/2019 Tyroid and Struma
2/52
-
7/30/2019 Tyroid and Struma
3/52
-
7/30/2019 Tyroid and Struma
4/52
Terletak dileher tengah, seperti kupu-kupu
Terdiri dari 2 lobus kiri& kanan yg dihubungkan
oleh isthmus N: sebesar ibu jari, berat 20 gr.
MProduksi hormon tiroid T3(iodotironin ) dan T4 (tiroksin)
-
7/30/2019 Tyroid and Struma
5/52
: mengatur metabolisme tubuh
Proses pembentukan tiroid diatur oleh hormon TSH (thyroitropin stimulating hormone) yg dihasilkan olehkelenjar pituitaria (hipofise) mll mekanisma umpan
balik
TSH sendiri bekerja dibawah pengaruh hormonTyrotropin releasing hormone ( TRH)di hipothalamus
Bila hormon tiroid rendah, TSH merangsang tiroid umemproduksi hormon tiroid ( Tiroksin daniodotironin)
-
7/30/2019 Tyroid and Struma
6/52
Untuk membentuk hormon tiroid dibutuhkanbahan mikronutrien yg berasal dari makanan.Antara lain iodium
WHO : kebutuhan iodium:
0-59 bln= 90 mcg 6-12 thn = 120 mcg
Dewasa = 150 mcg
Ibu hamil = 200 mcg
GAKY= Kekurangan Yodium
-
7/30/2019 Tyroid and Struma
7/52
Pembesaran kelenjar tiroid
Gangguan fungsi tiroid
Karsinoma
GAKY
-
7/30/2019 Tyroid and Struma
8/52
STRUMA=GONDOK;
Pembengkakan di leher (di bawah jakun ataularynx) karena kelenjar thyroid yang
membesar.
Didaerah non endemik sering ditemukan simple
diffusegoiter(pembesaran rata) ataustruma nodosa/multinodosa
-
7/30/2019 Tyroid and Struma
9/52
1. hipertiroid = produksi hormon tiroidyang berlebihan
2. hipotiroid = produksi hormon tiroidkurang
-
7/30/2019 Tyroid and Struma
10/52
Etiologi: auto imun , terkait dg genetik
Wanita : pria =4:1
Tubuh membentuk zat anti thd sel-seltiroid. Bila zat anti tsb merangsang(stimulator) menyebabkan produksi hormon
tiroid meningkat & kadar TSH tertekan seperti pada Graves dissease
-
7/30/2019 Tyroid and Struma
11/52
Struma nodosa toksik
Struma multinodosa toksik
tiroiditis
-
7/30/2019 Tyroid and Struma
12/52
Berdebar-debar = palpitasi
Keringat banyak
Lemas, makan banyak tapi BB menurun
Kulit hangat,halus dan lembab
Tremor,Oftalmopati, takikardi
Refleks fisiologis meningkat
-
7/30/2019 Tyroid and Struma
13/52
Struma
Bruit, eksoptalmus, proptosis,
Refleks fisiologi meningkat, periodikparalisis
Krisis tiroid
laboratorium TsH rendah ( sgt rendah)
T4 / fT4 dan T3 meningkat
-
7/30/2019 Tyroid and Struma
14/52
-
7/30/2019 Tyroid and Struma
15/52
Kadar hormaon tiroid ( T3,fT4, T4 danTsH & TsHs)
USG tiroid Sidik tiroid ( scan tiroid & Tc 99 dan I
131)
Ro toraks (tiroid retrosternal) EKG ( Atrium fibrilasi )
-
7/30/2019 Tyroid and Struma
16/52
Medikamentosa : Propiltiourasil,Metimazol
Prinsip terapi :dosis tinggi bertahap
diturunkan sesuai respons klinis danlaboratorium
operatif
Radiasi internal dg I 131
-
7/30/2019 Tyroid and Struma
17/52
-
7/30/2019 Tyroid and Struma
18/52
Etiologi:
autoimun= Hoshimoto
Pasca ablasi tiroid
Tiroiditis
Kelainan kongenital
-
7/30/2019 Tyroid and Struma
19/52
Keluhan: bervariasi dari samar sampai jelastergantung kaar hormon dan lama prosespenyakitnya
Cepat cape,Mengantuk,tidakbergairah,Depresi
Ggn konsentrasi, ggn mental, tidak tahandingin, suara parau, BB meningkat, nafsumakan kurang, sulit BAB, ggn menstruasi nyerisendi dan kesemutan
-
7/30/2019 Tyroid and Struma
20/52
Kulit kering,lamban, bicara lambat, suaraserak, sulit konsentrasi, sembab,reflekslamban dan menurun.
Dapat menaikkan kadar lemak darah danfc risiko untuk penyakit jantung koronerdan stroke
-
7/30/2019 Tyroid and Struma
21/52
Etiologi: ggn fgs kelenjar tiroid
ibu menderita kekurangan iodium
Klinis:
- Ggn pertumbuhan fisik ( cebol )
- Ggn tingkat kecerdasan
- Keterbelakangan mental
-
7/30/2019 Tyroid and Struma
22/52
bila diketahui sedini mungkin diberikanterpai hormon tiroid ( tiroksin ) seumur
hidup
-
7/30/2019 Tyroid and Struma
23/52
Terdiri atas:
Ca tiroid berdiferensiasi sedang
Ca Tirod medullare Ca tiroid tidak berdifferensiasi (anaplastik)
Ca jenis lainnya
-
7/30/2019 Tyroid and Struma
24/52
Nodul di kelenjar tiroid membesar danmendesak jaringan sekitarnya
Terjadi ggn menelan, suara serak
Diserta pembesaran kelenjar getah beningleher,stadium lanjut menyebar ke tulang, otak,paru-paru
Ca tiroid anaplastik paling ganas Ca tiroid berdifferensiasi relatif jinak
-
7/30/2019 Tyroid and Struma
25/52
ETIOLOGI:
Kekurangan asupan yodium saat dikandungan danbalita
Gejala klinis:ggn pertumbuhan fisik dan mental,
IQ rendah, infertilitas Daerah kantong endemis :
Dieng ( Jateng)
Tengger (Jateng )
Bukit Barisan ( Gayo/ aceh dan Sumbar)
-
7/30/2019 Tyroid and Struma
26/52
Kadar hormon tiroid ( TsH dan TsHs):
Bila kadar rendah lanjutkan dgnpemeriksaan kadar hormon tiroid
T3 dan T4 atau fT4. Kadar fT4 lebihspesifik karena tidak dipengaruhi olehprotein yang disebut dengan thyroxine
binding globulin (TBG ) Kusus pada wanita hamil dgn TBG tinggi
HARUS diperiksa fT4
-
7/30/2019 Tyroid and Struma
27/52
Hipertiroid: Tsh/TsHs rendah dan T3 & fT4 (hormon tiroid ) tinggi
Hipertiroid subklinik: Hormon tiroid normal, tapi TsH/TsHs rendah
Hipotiroid: Tsh/TsHs tinggi dan hormon tiroid rendah
Hipotoroid subklinis :
TsHs tinggi dan hormon tiroid normal
-
7/30/2019 Tyroid and Struma
28/52
Usg: nodul soliter, multinodul, nodul kistik padatatau campuran.
Hipervaskularisasi:menggambarkan,hiperfungsi
kelenjar tiroid
Batas tegas/ tidak. Kalsifikasi/tidak.
Scan tiroid I131:cold/warm nodul 10 -15% cold nodul adalah ca Tiroid
-
7/30/2019 Tyroid and Struma
29/52
Biopsi aspirasi jarum halus
Penting untuk diagnostik keganasan nodultiroid
Menggunakan jarum halus untuk mengambilsedikit jaringan tiroid
-
7/30/2019 Tyroid and Struma
30/52
Menggunakan yodium radioaktif I131,I123 Atau Tc99m pertechnetate)
Dapat ditentukan apakah high uptake(graves diseasses) atau low uptake(iatrogenic hypertiroidsm/ tyroiditis)
Menentukan dosis terapi I131
-
7/30/2019 Tyroid and Struma
31/52
-
7/30/2019 Tyroid and Struma
32/52
-
7/30/2019 Tyroid and Struma
33/52
-
7/30/2019 Tyroid and Struma
34/52
Ultrasonography
Ultrasonography can accurately detect nonpalpable nodules, estimate thesize of the nodule and the volume of the goiter, and differentiate simple
cysts, which have a low risk of being malignant, from solid nodules orfrom mixed cystic and solid nodules, which have a 5 percent risk of beingmalignant (Figure 3). Ultrasonography also provides guidance fordiagnostic procedures (e.g., fine-needle aspiration biopsy) as well astherapeutic procedures (e.g., cyst aspiration, ethanol injection, or lasertherapy) and facilitates the monitoring of the effects of treatment.9 In one
study, among patients who had been referred for evaluation of a palpablethyroid abnormality, ultrasonography altered the clinical management intwo thirds of cases,14 mainly by identifying nodules that were smallerthan 1 cm (which were not considered to require further evaluation) in 20percent of the patients and by discovering additional nodules (whichrequired biopsy) in 24 percent of the patients. Characteristics revealed by
ultrasonography
such as hypoechogenicity, microcalcifications,irregular margins, increased nodular flow visualized by Doppler, and,especially, the evidence of invasion or regional lymphadenopathy areassociated with an increased risk of cancer; however, sonographicfindings cannot reliably distinguish between benign and cancerouslesions.9
Other Methods
-
7/30/2019 Tyroid and Struma
35/52
Other Methods
Computed tomography (CT) and magnetic resonance imaging also cannot reliably differentiate betweenmalignant and benign nodules. These tests are rarely indicated in the evaluation of a nodule. An exception is inthe diagnosis and evaluation of substernal goiters, since these imaging techniques can assess the extent of thegoiter more precisely than can other techniques and can evaluate tracheal compression.3,15 Evaluation ofglucose metabolism by positron-emission tomography using fludeoxyglucose (fluorodeoxyglucose) F 18 mayhelp in distinguishing benign from malignant nodules, but its use is limited by cost and accessibility16 and it
cannot replace biopsy.
Fine-Needle Aspiration Biopsy
Independent of morphology, fine-needle aspiration provides the most direct and specific information about athyroid nodule. It is performed on an outpatient basis,1,4,5 is relatively inexpensive, and is easy to learn.Complications are rare and primarily involve local discomfort. The use of anticoagulants or salicylates does notpreclude biopsy. In centers with experience in fine-needle aspiration, the use of this technique has beenestimated to reduce the number of thyroidectomies by approximately 50 percent, to roughly double the
surgical confirmation of carcinoma, and to reduce the overall cost of medical care by 25 percent,17 ascompared with surgery performed on the basis of clinical findings alone.
Fine-needle aspiration has diagnostically useful results in about 80 percent of cases,18 typically with two tofour passes of the needle. The number of cases in which sufficient samples are obtained increases if aspirationis guided by ultrasonography, especially in nodules that are partly cystic, and repeated biopsy reduces by halfthe rate of insufficient samples (to about 10 percent).19,20 The diagnostic accuracy of fine-needle aspirationdepends on the way in which suspicious lesions are handled. Viewing them as "positive" increases sensitivity(rate of false negative results, 1 percent), but decreases specificity.21 If fine-needle aspiration reveals a
follicular neoplasm (which occurs in approximately 15 percent of nodules, of which only 20 percent turn out tobe malignant), radionuclide scanning should be performed.1,2,3 If such scanning shows a functioning nodulewith or without complete suppression of the rest of the thyroid, surgery can be avoided, since the risk of canceris negligible.17 In a cystic lesion or one that is a mixture of cystic and solid components, fine-needle aspirationof a possible solid component should be performed, since the risk of cancer is the same as that for a solidnonfunctioning nodule.2,20,21 With the exception of calcitonin immunostaining for medullary carcinoma,there are no reliable immunohistologic or molecular tests for distinguishing between benign and malignantnodules.3
Treatment of the Solitary Thyroid Nodule
-
7/30/2019 Tyroid and Struma
36/52
-
7/30/2019 Tyroid and Struma
37/52
-
7/30/2019 Tyroid and Struma
38/52
Surgery
The main indications for surgery are clinical orcytologic features suggestive of cancer orsymptoms due to the nodule (Table 1).4,5 Ifpreoperative cytology suggests a benign lesion,hemithyroidectomy is generally preferred.4,5,18
Postoperative administration of levothyroxine isindicated only in cases of hypothyroidism.34When surgery is performed by a specialist, theincidence of complications is low (i.e.,postoperative hypoparathyroidism in 1 percent ofcases and injuries to the recurrent laryngeal nervein about 1 percent), but the complication rate ishigher for less experienced surgeons and thosewithout special training.35
-
7/30/2019 Tyroid and Struma
39/52
Radioiodine
Radioiodine is an option for treatment of a functioning nodule,with or without biochemical hyperthyroidism. It iscontraindicated in pregnant and breast-feeding women.Normalization of the results of thyroid radionuclide scanning andthe serum thyrotropin level (often referred to as a "cure") isachieved in 75 percent of patients, and thyroid volume is reducedan average of 40 percent, after a single dose of iodine-131 aiming
at a level of 100 Gy, independent of pretreatment thyroidfunction.36,37 The main side effect is hypothyroidism, whichoccurs in approximately 10 percent of patients within five yearsafter treatment and increases in frequency over time. This risk isunrelated to dose but is greater in patients with thyroidperoxidase antibodies and with iodine uptake in extranodular
thyroid tissue.36,37 Most nodules do not disappear afterradioiodine therapy but may become harder on palpation andmay reveal unusual cytologic features as a result of irradiation.Thyroid function should be checked regularly during the first yearand yearly thereafter in order to detect hypothyroidism. Nodulesare unlikely to grow after radioiodine therapy, but if growthoccurs, a biopsy may be warranted.
-
7/30/2019 Tyroid and Struma
40/52
Areas of Uncertainty
There are no data from studies comparing the
outcome and cost-effectiveness of variousstrategies of evaluating a nodule (e.g., usingradionuclide imaging and ultrasonographicguidance for fine-needle aspiration). There arealso insufficient data comparing the outcome(including quality of life) of variousmanagement approaches in the absence ofcancer.
-
7/30/2019 Tyroid and Struma
41/52
Guidelines from Professional Societies
Clinical-practice guidelines were published in 1996 by the
American Thyroid Association1(www.thyroid.org/professionals/publications/guidelines.html) and the American Association of ClinicalEndocrinologists46(www.aace.com/clin/guidelines/thyroid_nodules.pdf). Therecommendations of both organizations correspond with
those provided here. Radionuclide scanning is not routinelyrecommended, but it is advocated in the case of asuppressed level of serum thyrotropin or the finding offollicular neoplasia with the use of fine-needle aspiration.Thyroid ultrasonography is recommended to guide fine-needle aspiration, especially in nodules that are small and
incidental or are partly cystic or from which primary fine-needle aspiration has yielded insufficient material. Fine-needle biopsy of all possibly malignant nodules (which arenot defined in the guidelines) is advocated. If the cytology isbenign, repeated biopsy is seldom indicated.
-
7/30/2019 Tyroid and Struma
42/52
In the case of a benign nodule, periodic lifelong follow-up every 6 to 24months (including measurement of serum thyrotropin levels, neckpalpation, and fine-needle aspiration in case of growth or othersuspicious signs) is recommended. For a functioning benign nodule,iodine-131 is considered the treatment of choice, with surgery as analternative, especially if the nodule is very large or partly cystic or if thepatient is young; treatment is more strongly recommended if the serum
thyrotropin level is decreased or overt hyperthyroidism is present,because of adverse effects on bone and the cardiovascular system. For anonfunctional benign nodule, there is no clear recommendation on theuse of levothyroxine, although this therapy is considered contraindicatedwhen the serum thyrotropin level is suppressed, in patients more than 60years old, and in postmenopausal women. If levothyroxine therapy isused, regular reassessment (the interval is not defined in the guidelines)
is recommended, with monitoring of serum thyrotropin levels, whichshould be subnormal but measurable. The guidelines do not addressethanol injection and laser therapy.
-
7/30/2019 Tyroid and Struma
43/52
Conclusions and Recommendations
For the patient who presents with a nodule, as in the case described in the vignette, the main concern is to exclude thepossibility of thyroid cancer, even though the vast majority of nodules are benign (Figure 1). The initial evaluationshould include measurement of the serum thyrotropin level and a fine-needle aspiration, preferably guided byultrasonography. If the patient has a family history of medullary thyroid carcinoma or multiple endocrine neoplasia type2, the serum calcitonin level should also be checked. If the thyrotropin level is suppressed, radionuclide scanning shouldbe performed. In patients less than 20 years old, and in the case of a high clinical suspicion for cancer (e.g., follicularneoplasia as diagnosed by fine-needle aspiration and a nonfunctioning nodule revealed on scanning), the patient shouldbe offered hemithyroidectomy regardless of the results of fine-needle aspiration.
In the case of a functioning benign nodule, iodine-131 is generally the therapy of choice, independent of concomitanthyperthyroidism. For nonfunctioning cystic nodules, aspiration and ethanol injection therapy may be considered, andethanol injection or laser therapy if the nodules are solid, but data to support the use of these therapies are limited. Myusual approach after documenting benign cytology is to follow the patient yearly with neck palpation and measurementof the serum thyrotropin level, with repeated ultrasonography and fine-needle aspiration if there is evidence of growthof the nodule. I do not recommend levothyroxine therapy to shrink or prevent growth of benign nodules because of thedrug's low efficacy and potential side effects.
Dr. Hegeds reports having received grants from the Agnes and Knut Mrk Foundation, the Novo Nordisk Foundation,and the A.P. Mller Relief Foundation.
I am indebted to Dr. Steen J. Bonnema and Dr. Finn N. Bennedbk for their helpful comments.
-
7/30/2019 Tyroid and Struma
44/52
Suatu keadaan emergensi (life threatening)Angka kematian 10 %Etiologi:
1.Peningkatan hormon tiroidmendadak.Penghentian obat-obat tiroid tiba-tiba, radiasi, palpasi tiroid secara kasar danakibat penggunaan iodium radioaktif
2 Keadaan diluar penyakit tiroid spt stressemosional,KAD atau hipoglikemi, stroke,infark atau emboli paru
-
7/30/2019 Tyroid and Struma
45/52
Demam tinggi
Takikardi
Ggn kesadaran
Ggn sal cerna ( mual, muntah nyeri abdomen,diare dan ikterus)
Gagal jantung
-
7/30/2019 Tyroid and Struma
46/52
Atasi fc pencetus Suportif cairan ,elektrolit,oksigen dan kompres
dingin
PTU 200-250 mg/4 jam kl perlu pasang ngt Yodida 1 jam stlh PTU. Berupa larutan lugol 8
tts tiap 8 jam atau potassium yodida 2x0,5-1 g Hidrokortison 100 mg/8 jam
Beta bloker: propanolol 60-120 mg/jam Plasmafareses Digoksin dan diuretik bila ada gagal jantung
-
7/30/2019 Tyroid and Struma
47/52
Idealnya penderita graves disease tidakhamil sampai kondisi eutiroid
Graves disease gejala klinik bisa mirip
dengan kehamilan Prevalensi 0,2 %
Sering terjadi remisi pada kehamilan tm ke3, tapi relaps kembali pasca persalinan (3-6bln kmdn)
-
7/30/2019 Tyroid and Struma
48/52
Hipertiroid mirip kehamilan shg hipertiroidpada kehamilan sering sulit terdeteksi
Pada kehamilan terjadi peningkatan klirensyodium oleh ginjal shg kadar yodiuminorganik diplasma turun sehingga kelenjartiroid hipeertropi dan hiperplasi untukmenangkap yodium lebih banyak.
Pada kehamilan juga terjadi peningkatanhormon estrogen sehingga kadar TBG ( tiroidbinding globulin) , T4 dan T3 total meningkat,shg hrs diperiksa FT4.
H
-
7/30/2019 Tyroid and Struma
49/52
Bila tidak terjadi kadar eutiroid bisa timbulkrisis tiroid, toksemia, partus prematurus,solusio plasenta dan gagal jantung.
Anak beresiko untuk menjadi BBLR dan fetaldeath.
Sebaliknya bila over treatment bisa terjadihipotiroid.
-
7/30/2019 Tyroid and Struma
50/52
PTU : dosis 3x50-150 mg
Efek samping bisa terjadi hipotiroid padajanin, ggn mental/intelektual janin ok PTU
bisa melewati BBB Trimester ke III kehamilan dosis harus
dikurangi 100-200 mg/hari
Begitu janin lahir harus dicek kadar hormontiroid janin untuk menghindari terjadinyakrisis tiroid
-
7/30/2019 Tyroid and Struma
51/52
Bila janin hipotiroid diberikan Ltiroksin(INUTERO)
Bila janin hipertiroid bisa diberikan PTU
dosis 10 mg/kgBB dibagi 3-4perlu PTU dosisbesar pada TM ! Atau alergi dengan PTU,struma makin besar atau pasien tidak bisamakan obat kalai pemberian
Larutan lugol 3x1 tts Remisi bisa terjadi dalam 1-6 bulan
Operasi dilakukan bila pasien
-
7/30/2019 Tyroid and Struma
52/52
BILA PASIEN ALERGI PTU
BUTUH DOSIS BESAR,
STRUMA MAKIN BESAR
Dilakukan pada TM 2 kehamilan